Clinical Trial: A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diffuse Large B-Cell Lymphoma
Study Type: INTERVENTIONAL
Official Title: A First In Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies
Brief Summary:
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections).Follicular Lymphoma is a slow-growing type of non-Hodgkin lymphoma.Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells).The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-319 in adult participants in relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), R/R…
Read more